Fibrocell Science Inc (FCSC)

[Kipperdo]

notes from today's UBS presentation:
- emphasized that this could be a $1B market cap company
-most material presented was same as previous rodman presentation
-discussed orphan drug status for both burn and vocal cord scars
-exploiting the UCLA platform to exploit alternative to stem cell
-may eventually yield 3-4 additional indications for brand
-laviv appearing in new issue of marie clair magazine
-pledge to derms and plastics exclusive use of product, as opposed to botox which can be administered by basically any nurse etc.
-rolling out "natural aire" agera skin care product
-publications will be out end of year
-upcoming dec plastic surgery conference in LV is intended for the "big splash"
-acne scarring completed phase II/III and in discussions with FDA now to conclude studies. potential 3-4 M market
-if approved will be the first and only product on the market FDA approved for this use (acne).
-burn scars success with treating patients as far back as 10 years prior
-access to patents at both UCLA and Stanford
-discussed potential market share, using moderate assumptions that could yield huge $$$
q and a session in another room. one question from audience related to stem cell , could not hear the entire question.

very upbeat.
on another topic anyone continue to observe the frequent 50-100 sells everytime the pps inches up 1 cent...very contrived imo and i'd be willing to place a bet on who that is!